Industry Growth Insights published a new data on “GABA Receptor Agonist Drug Market”. The research report is titled “GABA Receptor Agonist Drug Market research by Types (Bamaluzole, Phenibut, Baclofen, Gaboxadol, Klonopin (clonazepam), Tiagbine), By Applications (Attention Deficit Hyperactivity Disorder (ADHD), Psychiatric Disorders and Depression, Alzheimer, Epilepsy and Seizure, Anxiety and Sleep Disorders, Obesity and Alcoholism), By Players/Companies Advicenne, AstraZeneca, Athena Drug Delivery Solutions, Biocodex, Elan Corporation, Eli Lilly and Company, H.LundBeck, Merck and Co, GlaxoSmithKline, NovaDel Pharma, Novartis, Advicenne, Osmotica Pharmaceutical, Pfizer, sanofi-aventis, VIVUS, XenoPort”.
Scope Of The Report
Report Attributes
Report Details
Report Title
GABA Receptor Agonist Drug Market Research Report
By Type
Bamaluzole, Phenibut, Baclofen, Gaboxadol, Klonopin (clonazepam), Tiagbine
By Application
Attention Deficit Hyperactivity Disorder (ADHD), Psychiatric Disorders and Depression, Alzheimer, Epilepsy and Seizure, Anxiety and Sleep Disorders, Obesity and Alcoholism
By Companies
Advicenne, AstraZeneca, Athena Drug Delivery Solutions, Biocodex, Elan Corporation, Eli Lilly and Company, H.LundBeck, Merck and Co, GlaxoSmithKline, NovaDel Pharma, Novartis, Advicenne, Osmotica Pharmaceutical, Pfizer, sanofi-aventis, VIVUS, XenoPort
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
169
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global GABA Receptor Agonist Drug Market Report Segments:
The global GABA Receptor Agonist Drug market is segmented on the basis of:
Types
Bamaluzole, Phenibut, Baclofen, Gaboxadol, Klonopin (clonazepam), Tiagbine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Attention Deficit Hyperactivity Disorder (ADHD), Psychiatric Disorders and Depression, Alzheimer, Epilepsy and Seizure, Anxiety and Sleep Disorders, Obesity and Alcoholism
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Advicenne
- AstraZeneca
- Athena Drug Delivery Solutions
- Biocodex
- Elan Corporation
- Eli Lilly and Company
- H.LundBeck, Merck and Co
- GlaxoSmithKline
- NovaDel Pharma
- Novartis
- Advicenne
- Osmotica Pharmaceutical
- Pfizer
- sanofi-aventis
- VIVUS
- XenoPort
Highlights of The GABA Receptor Agonist Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bamaluzole
- Phenibut
- Baclofen
- Gaboxadol
- Klonopin (clonazepam)
- Tiagbine
- By Application:
- Attention Deficit Hyperactivity Disorder (ADHD)
- Psychiatric Disorders and Depression
- Alzheimer
- Epilepsy and Seizure
- Anxiety and Sleep Disorders
- Obesity and Alcoholism
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the GABA Receptor Agonist Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
GABA receptor agonist drugs are medications that bind to the GABA receptors and increase the activity of these receptors. This can result in decreased anxiety and improved mood.
Some of the major companies in the gaba receptor agonist drug market are Advicenne, AstraZeneca, Athena Drug Delivery Solutions, Biocodex, Elan Corporation, Eli Lilly and Company, H.LundBeck, Merck and Co, GlaxoSmithKline, NovaDel Pharma, Novartis, Advicenne, Osmotica Pharmaceutical, Pfizer, sanofi-aventis, VIVUS, XenoPort.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 GABA Receptor Agonist Drug Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 GABA Receptor Agonist Drug Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 GABA Receptor Agonist Drug Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the GABA Receptor Agonist Drug Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global GABA Receptor Agonist Drug Market Size & Forecast, 2020-2028 4.5.1 GABA Receptor Agonist Drug Market Size and Y-o-Y Growth 4.5.2 GABA Receptor Agonist Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Bamaluzole
5.2.2 Phenibut
5.2.3 Baclofen
5.2.4 Gaboxadol
5.2.5 Klonopin (clonazepam)
5.2.6 Tiagbine
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Attention Deficit Hyperactivity Disorder (ADHD)
6.2.2 Psychiatric Disorders and Depression
6.2.3 Alzheimer
6.2.4 Epilepsy and Seizure
6.2.5 Anxiety and Sleep Disorders
6.2.6 Obesity and Alcoholism
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global GABA Receptor Agonist Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 GABA Receptor Agonist Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Bamaluzole
9.6.2 Phenibut
9.6.3 Baclofen
9.6.4 Gaboxadol
9.6.5 Klonopin (clonazepam)
9.6.6 Tiagbine
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Attention Deficit Hyperactivity Disorder (ADHD)
9.10.2 Psychiatric Disorders and Depression
9.10.3 Alzheimer
9.10.4 Epilepsy and Seizure
9.10.5 Anxiety and Sleep Disorders
9.10.6 Obesity and Alcoholism
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Bamaluzole
10.6.2 Phenibut
10.6.3 Baclofen
10.6.4 Gaboxadol
10.6.5 Klonopin (clonazepam)
10.6.6 Tiagbine
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Attention Deficit Hyperactivity Disorder (ADHD)
10.10.2 Psychiatric Disorders and Depression
10.10.3 Alzheimer
10.10.4 Epilepsy and Seizure
10.10.5 Anxiety and Sleep Disorders
10.10.6 Obesity and Alcoholism
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Bamaluzole
11.6.2 Phenibut
11.6.3 Baclofen
11.6.4 Gaboxadol
11.6.5 Klonopin (clonazepam)
11.6.6 Tiagbine
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Attention Deficit Hyperactivity Disorder (ADHD)
11.10.2 Psychiatric Disorders and Depression
11.10.3 Alzheimer
11.10.4 Epilepsy and Seizure
11.10.5 Anxiety and Sleep Disorders
11.10.6 Obesity and Alcoholism
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Bamaluzole
12.6.2 Phenibut
12.6.3 Baclofen
12.6.4 Gaboxadol
12.6.5 Klonopin (clonazepam)
12.6.6 Tiagbine
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Attention Deficit Hyperactivity Disorder (ADHD)
12.10.2 Psychiatric Disorders and Depression
12.10.3 Alzheimer
12.10.4 Epilepsy and Seizure
12.10.5 Anxiety and Sleep Disorders
12.10.6 Obesity and Alcoholism
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Bamaluzole
13.6.2 Phenibut
13.6.3 Baclofen
13.6.4 Gaboxadol
13.6.5 Klonopin (clonazepam)
13.6.6 Tiagbine
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Attention Deficit Hyperactivity Disorder (ADHD)
13.10.2 Psychiatric Disorders and Depression
13.10.3 Alzheimer
13.10.4 Epilepsy and Seizure
13.10.5 Anxiety and Sleep Disorders
13.10.6 Obesity and Alcoholism
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 GABA Receptor Agonist Drug Market: Competitive Dashboard
14.2 Global GABA Receptor Agonist Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Advicenne
14.3.2 AstraZeneca
14.3.3 Athena Drug Delivery Solutions
14.3.4 Biocodex
14.3.5 Elan Corporation
14.3.6 Eli Lilly and Company
14.3.7 H.LundBeck, Merck and Co
14.3.8 GlaxoSmithKline
14.3.9 NovaDel Pharma
14.3.10 Novartis
14.3.11 Advicenne
14.3.12 Osmotica Pharmaceutical
14.3.13 Pfizer
14.3.14 sanofi-aventis
14.3.15 VIVUS
14.3.16 XenoPort